Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
Drug Design, Development and Therapy · 2026-08 · Volume 20 · 1-13
DOI: 10.2147/dddt.s607942 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-08. Verfasst von Kuo-Mao Lan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Chi Mei Hospital, Liouying, Tainan City, Taiwan. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Sugammadex, Venous Thrombosis. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Chi Mei Hospital, Liouying, Tainan City, Taiwan.
- Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan.
- Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan.
ORCID-Profile: Kuo-Mao Lan
Zitieren
APA
Lan, K. M., Kao, C. L., & Chang, Y. J. (2026). Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis. Drug Design, Development and Therapy, Volume 20, 1-13. https://doi.org/10.2147/dddt.s607942
Vancouver
Lan KM, Kao CL, Chang YJ. Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis. Drug Design, Development and Therapy. 2026;Volume 20:1-13. doi:10.2147/dddt.s607942
BibTeX
@article{Lan2026,
author = {Lan, Kuo-Mao and Kao, Chia-Li and Chang, Ying-Jen},
title = {Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--13},
doi = {10.2147/dddt.s607942}
}
EUVIMED